目次

I. Background1. Precision Medicine of Lung Cancer: Introduction2. Lung Cancer Epidemiology and Demographics3. Genetic Susceptibility to Lung Cancer4. Lung Cancer Stem Cells5. The 2015 World Health Organization Classification of Lung Cancer: OverviewII. Testing Methods6. Preanalytic considerations7. Mutation testing of lung cancer biomarkers8. Translocation testing of lung cancer biomarkers9. Immunohistochemistry of lung cancer biomarkers10. Next Generation and Third Generation Sequencing of lung cancer biomarkersIII. Molecular Pathology of Specific Cell Types11. Mutations as Predictive Biomarkers for Adenocarcinoma12. Translocations as predictive Biomarkers for Adenocarcinoma13. Predictive Biomarkers for Squamous Cell Carcinoma14. Molecular Pathology of Small Cell Carcinoma15. Molecular Pathology of Uncommon Carcinomas16. Molecular Pathology of Lung Cancer Metastases17. Molecular Pathology of Precursor and Preinvasive LesionsIV. General and Emerging Fields in Molecular Pathology of Lung Cancer18. Prognostic biomarkers in lung cancer19. Biomarkers and Differing Therapy Modalities20. Immuno-oncology of Lung Cancer21. Liquid Biopsy.